Biogen, with a $54.1 billion market cap, "could be worth twice that if all goes well" with regulators, Jim Cramer says.
- Күн бұрын
Cramer: This biotech stock could be worth over $100 billion on an FDA approval
- Рет қаралды 407,508
Biogen, with a $54.1 billion market cap, "could be worth twice that if all goes well" with regulators, Jim Cramer says.
Пікірлер: 483